Advertisement

Topics

STAT Plus: U.S. panel considers giving a nod to new vaccine, and a competitor objects

10:27 EDT 22 Jun 2017 | STAT

A panel that advises the CDC may indicate a shingles vaccines awaiting possible FDA approval is preferable to a competitor that is already on the market.

Original Article: STAT Plus: U.S. panel considers giving a nod to new vaccine, and a competitor objects

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: U.S. panel considers giving a nod to new vaccine, and a competitor objects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...